| Vol. 16.08 – 5 March, 2024 |
| |
|
|
| Using single-cell analysis, scientists characterized the cellular identities present in human amniotic fluid. Theyidentified and isolated viable epithelial stem/progenitor cells of fetal gastrointestinal, renal, and pulmonary origin. [Nature Medicine] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| The authors found that the expression of orphan nuclear receptor Nr4a1, an endogenous repressor of TGF-β1, was suppressed directly by TGF-β1-induced Smad3 and indirectly by Hdac4, respectively. [Molecular Therapy] |
|
|
|
| Investigators explored the impact of MSCs on the differentiation of hematopoietic stem/progenitor cells and progenitors through the C-C motif chemokine CCL2/CCR2 signaling pathway. [Stem Cell Reports] |
|
|
|
| Researchers studied the viability, proliferation, and osteogenic differentiation of human bone marrow-derived MSCs when subjected to five different electrical stimulation protocols. [Scientific Reports] |
|
|
|
| Investigators explored the effects and possible regulatory mechanisms of Lin28 on the proliferation and differentiation of human dental pulp stem cells. [BDJ Open] |
| |
|
|
| MSCs were stimulated with nerve growth factor to regulate exosomal cargoes to improve neuro-promotive potential and facilitate innervated bone regeneration. [ACS Nano] |
|
|
|
| DNA-based self-assembled composites were reported that could aid the adhesion of MSCs in skin wounds, enhance MSC viability, and accelerate wound closure and re-epithelialization. [Small] |
|
|
|
| Single-cell RNA sequencing with in vivo lineage tracing in non-alcoholic steatohepatitismodel mice reveals a subpopulation of HSCs transitioning back to a state resembling their developmental precursors, mesothelial cells, after liver injury. [Molecular Therapy] |
|
|
|
| Using a trans-vessel wall device, investigators delivered chemically modified mRNAs and mRNA-enhanced mesenchymal stromal cells expressing Vascular Endothelial Growth Factor A directly to the heart. [Molecular Therapy-Methods & Clinical Development] |
|
|
|
|
|
| A gap currently exists between the promising biological factors which have been investigated in animal models and the rotator cuff repair grafts that can be used in the clinical setting. [Tissue Engineering Part B-Reviews] |
|
|
|
|
| CytoMed Therapeutics Limited announced that it has entered into a Research Collaboration Agreement with Sengkang General Hospital Pte Ltd to establish proof-of-concept use of an injectable cartilage regeneration therapy that has been developed with donor-sourced, umbilical cord-derived MSCs to treat cartilage injury. [CytoMed Therapeutics Limited] |
|
|
|
|
| April 14 – 17, 2024 Glasgow, Scotland, United Kingdom |
|
|
|
|
|
| King’s College London – London, England, United Kingdom |
|
|
|
| University of Sydney – Sydney, Australia |
|
|
|
| UC Davis – Davis, California, United States |
|
|
|
| BC Provincial Health Services Authority – Vancouver, British Columbia, Canada |
|
|
|
| Universitätsklinikum Ulm – Ulm, Germany |
|
|
|
|